Prothymosin alpha protects cardiomyocytes against ischemia-induced apoptosis via preservation of Akt activation

[1]  D. Leosco,et al.  Myocardial β2‐adrenoceptor gene delivery promotes coordinated cardiac adaptive remodelling and angiogenesis in heart failure , 2012, British journal of pharmacology.

[2]  D. Leosco,et al.  Targeting the &bgr;-Adrenergic Receptor System Through G-Protein–Coupled Receptor Kinase 2: A New Paradigm for Therapy and Prognostic Evaluation in Heart Failure From Bench to Bedside , 2012, Circulation. Heart failure.

[3]  G. Dorn,et al.  GRK2 Activity Impairs Cardiac Glucose Uptake and Promotes Insulin Resistance Following Myocardial Ischemia , 2011 .

[4]  G. Dorn,et al.  G Protein–Coupled Receptor Kinase 2 Activity Impairs Cardiac Glucose Uptake and Promotes Insulin Resistance After Myocardial Ischemia , 2011, Circulation.

[5]  D. Leosco,et al.  GRK2 as a novel gene therapy target in heart failure. , 2011, Journal of molecular and cellular cardiology.

[6]  P. Grieco,et al.  EGFR trans-activation by urotensin II receptor is mediated by β-arrestin recruitment and confers cardioprotection in pressure overload-induced cardiac hypertrophy , 2011, Basic Research in Cardiology.

[7]  W. Koch,et al.  Adrenal beta-arrestin 1 inhibition in vivo attenuates post-myocardial infarction progression to heart failure and adverse remodeling via reduction of circulating aldosterone levels. , 2011, Journal of the American College of Cardiology.

[8]  G. Gusella,et al.  Prothymosin-α inhibits HIV-1 via Toll-like receptor 4-mediated type I interferon induction , 2010, Proceedings of the National Academy of Sciences.

[9]  G. Dorn,et al.  Reduction of Sympathetic Activity via Adrenal-targeted GRK2 Gene Deletion Attenuates Heart Failure Progression and Improves Cardiac Function after Myocardial Infarction* , 2010, The Journal of Biological Chemistry.

[10]  W. Koch,et al.  An adrenal β-arrestin 1-mediated signaling pathway underlies angiotensin II-induced aldosterone production in vitro and in vivo , 2009, Proceedings of the National Academy of Sciences.

[11]  W. Koch,et al.  Myocardial Adeno-Associated Virus Serotype 6–&bgr;ARKct Gene Therapy Improves Cardiac Function and Normalizes the Neurohormonal Axis in Chronic Heart Failure , 2009, Circulation.

[12]  F. Rengo,et al.  Exercise promotes angiogenesis and improves beta-adrenergic receptor signalling in the post-ischaemic failing rat heart. , 2008, Cardiovascular research.

[13]  Francesco Prati,et al.  From bench to bedside: a novel technique of acquiring OCT images. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[14]  R. Kitsis,et al.  Introduction—cell death in heart failure , 2008, Heart Failure Reviews.

[15]  W. Koch,et al.  Adrenal adrenoceptors in heart failure: fine-tuning cardiac stimulation. , 2007, Trends in molecular medicine.

[16]  K. Mani,et al.  Nipping at cardiac remodeling. , 2007, The Journal of clinical investigation.

[17]  S. Elmore.  Apoptosis: A Review of Programmed Cell Death , 2007, Toxicologic pathology.

[18]  H. Ueda,et al.  Identification of prothymosin-α1, the necrosis–apoptosis switch molecule in cortical neuronal cultures , 2007, The Journal of cell biology.

[19]  F. Domínguez,et al.  Apoptotic and proliferating hepatocytes differ in prothymosin α expression and cell localization , 2006, Molecular and Cellular Biochemistry.

[20]  F. Domínguez,et al.  Apoptotic and proliferating hepatocytes differ in prothymosin alpha expression and cell localization. , 2006, Molecular and cellular biochemistry.

[21]  M. Frangou-Lazaridis,et al.  Surfing on prothymosin alpha proliferation and anti-apoptotic properties. , 2006, Neoplasma.

[22]  Ana Canda-Sánchez,et al.  Prothymosin alpha-receptor associates with lipid rafts in PHA-stimulated lymphocytes , 2005, Molecular membrane biology.

[23]  L. Kirshenbaum,et al.  Apoptosis of ventricular myocytes: a means to an end. , 2005, Journal of molecular and cellular cardiology.

[24]  R. Gottlieb,et al.  Ischemia/reperfusion injury at the intersection with cell death. , 2005, Journal of molecular and cellular cardiology.

[25]  Young-Jae Nam,et al.  The Mitochondrial Death Pathway and Cardiac Myocyte Apoptosis , 2004, Circulation research.

[26]  D. Golde,et al.  Vitamin C inhibits hypoxia-induced damage and apoptotic signaling pathways in cardiomyocytes and ischemic hearts. , 2004, Free radical biology & medicine.

[27]  A. Rosenzweig,et al.  Akt and PI 3-Kinase Signaling in Cardiomyocyte Hypertrophy and Survival , 2003, Cell cycle.

[28]  K. Mani,et al.  Myocyte apoptosis: programming ventricular remodeling. , 2003, Journal of the American College of Cardiology.

[29]  E. Hannappel,et al.  The thymosins. Prothymosin alpha, parathymosin, and beta-thymosins: structure and function. , 2003, Vitamins and hormones.

[30]  S. Cook,et al.  Transcriptional Effects of Chronic Akt Activation in the Heart* , 2002, The Journal of Biological Chemistry.

[31]  R. Lefkowitz,et al.  β-Arrestin Scaffolding of the ERK Cascade Enhances Cytosolic ERK Activity but Inhibits ERK-mediated Transcription following Angiotensin AT1a Receptor Stimulation* , 2002, The Journal of Biological Chemistry.

[32]  Afshin Samali,et al.  Losing heart: the role of apoptosis in heart disease—a novel therapeutic target? , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  R. Kitsis,et al.  The MEK1–ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice , 2000, The EMBO journal.

[34]  N. Sharpe,et al.  Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. , 2000, Circulation.

[35]  R. Kitsis,et al.  Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. , 2000, Circulation.

[36]  V. Agol,et al.  Prothymosin α fragmentation in apoptosis , 2000 .

[37]  A. Saraste.  Morphologic criteria and detection of apoptosis , 1999, Herz.

[38]  John Calvin Reed,et al.  Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[39]  M. Freire,et al.  Synthesis and apparent secretion of prothymosin alpha by different subpopulations of calf and rat thymocytes. , 1989, Immunology.

[40]  B. Horecker,et al.  Prothymosin alpha in human blood. , 1987, Proceedings of the National Academy of Sciences of the United States of America.